<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2024-07-19 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment." The draft guidance was prepared by the Division of Gastroenterology in the Center for Drug Evaluation and Research at FDA to help sponsors in the clinical development of drugs to treat pediatric patients with inflammatory bowel disease. The draft guidance provides FDA's recommendations about the necessary...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2024-15942</p>
    <p><strong>Publication Date:</strong> 2024-07-19</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2024/07/19/2024-15942/pediatric-inflammatory-bowel-disease-developing-drugs-for-treatment-draft-guidance-for-industry">https://www.federalregister.gov/documents/2024/07/19/2024-15942/pediatric-inflammatory-bowel-disease-developing-drugs-for-treatment-draft-guidance-for-industry</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2024-15942</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
